PYXS

Pyxis Oncology, Inc. Common Stock

3.22

USD

-0.13

-4.02%

Sep 23, 15:58 UTC -4

Closed

After-Market

3.25

+0.03

+0.93%

Pyxis Oncology, Inc. Common Stock Profile

About

Pyxis Oncology Inc. is a preclinical oncology company. It focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers. The company's product pipeline includes antibody drug conjugate and monoclonal antibody. Pyxis Oncology Inc. is based in CAMBRIDGE, Mass.

Info & Links

CEO

Thomas Civik

Headquarters

321 HARRISON AVENUE
BOSTON, MA 02118, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

Pyxis Oncology, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

271.08M

Enterprise Value

250.75M

Enterprise Value/EBITDA(ttm)

-2.81

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

17.69

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

19.59%

Operating Margin(ttm)

Profit Margin(ttm)

-41.01%

Return on Equity(ttm)

-215.23%

Return on Invested Capital(ttm)

-361.88%

Return on Assets(ttm)

-112.19%

Income Statement

Revenue(ttm)

11.04M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

8.65M

EBITDA(ttm)³

-89.26M

Net Income Available to Common(ttm)

-88.73M

Diluted EPS(ttm)

-1.41

Share Statistics

Beta (5Y Monthly)

1.34

52-Week Change

48.39%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

83.41M

Dividend Yield

0.00%

Float⁴

78.65M

% Held by Insiders

5.70%

% Held by Institutions

39.07%

Balance Sheet

Total Cash(mrq)

34.47M

Total Cash Per Share(mrq)

0.41

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.34%

Quick Ratio(mrq)

1.34%

Book Value Per Share(mrq)

0.18

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.69

Free Cash Flow(ytd)

-44.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.